113 related articles for article (PubMed ID: 35786686)
41. Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.
Ha H; Shim KS; An H; Kim T; Ma JY
BMC Complement Altern Med; 2013 May; 13():112. PubMed ID: 23692684
[TBL] [Abstract][Full Text] [Related]
42. Osteoclastic resorption of biomimetic calcium phosphate coatings in vitro.
Leeuwenburgh S; Layrolle P; Barrère F; de Bruijn J; Schoonman J; van Blitterswijk CA; de Groot K
J Biomed Mater Res; 2001 Aug; 56(2):208-15. PubMed ID: 11340590
[TBL] [Abstract][Full Text] [Related]
43. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY
Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364
[TBL] [Abstract][Full Text] [Related]
44. A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells.
Takada Y; Kusuda M; Hiura K; Sato T; Mochizuki H; Nagao Y; Tomura M; Yahiro M; Hakeda Y; Kawashima H
Bone Miner; 1992 Jun; 17(3):347-59. PubMed ID: 1623329
[TBL] [Abstract][Full Text] [Related]
45. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
46. An Ammonia-Induced Calcium Phosphate Nanostructure: A Potential Assay for Studying Osteoporosis and Bone Metastasis.
Chen S; Wang Q; Eltit F; Guo Y; Cox M; Wang R
ACS Appl Mater Interfaces; 2021 Apr; 13(15):17207-17219. PubMed ID: 33845570
[TBL] [Abstract][Full Text] [Related]
47. Lycopene I--effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures.
Rao LG; Krishnadev N; Banasikowska K; Rao AV
J Med Food; 2003; 6(2):69-78. PubMed ID: 12935316
[TBL] [Abstract][Full Text] [Related]
48. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.
Vitté C; Fleisch H; Guenther HL
Endocrinology; 1996 Jun; 137(6):2324-33. PubMed ID: 8641182
[TBL] [Abstract][Full Text] [Related]
49. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.
Kanatani M; Sugimoto T; Nishiyama K; Chihara K
J Bone Miner Res; 2000 May; 15(5):902-10. PubMed ID: 10804020
[TBL] [Abstract][Full Text] [Related]
50. Human osteoclast culture and phenotypic characterization.
Agrawal A; Gallagher JA; Gartland A
Methods Mol Biol; 2012; 806():357-75. PubMed ID: 22057463
[TBL] [Abstract][Full Text] [Related]
51. Gender- and age-related differences in osteoclast formation from circulating precursors.
Jevon M; Sabokbar A; Fujikawa Y; Hirayama T; Neale SD; Wass J; Athanasou NA
J Endocrinol; 2002 Mar; 172(3):673-81. PubMed ID: 11874715
[TBL] [Abstract][Full Text] [Related]
52. Increased levels of sodium chloride directly increase osteoclastic differentiation and resorption in mice and men.
Wu L; Luthringer BJC; Feyerabend F; Zhang Z; Machens HG; Maeda M; Taipaleenmäki H; Hesse E; Willumeit-Römer R; Schilling AF
Osteoporos Int; 2017 Nov; 28(11):3215-3228. PubMed ID: 28849275
[TBL] [Abstract][Full Text] [Related]
53. In vitro effects of particulate bone substitute materials on the resorption activity of human osteoclasts.
Russmueller G; Winkler L; Lieber R; Seemann R; Pirklbauer K; Perisanidis C; Kapeller B; Spassova E; Halwax E; Poeschl WP; Macfelda K; Moser D
Eur Cell Mater; 2017 Oct; 34():291-306. PubMed ID: 29064533
[TBL] [Abstract][Full Text] [Related]
54. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
55. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
[TBL] [Abstract][Full Text] [Related]
56. Pit Assay to Measure the Bone Resorptive Activity of Bone Marrow-derived Osteoclasts.
Vesprey A; Yang W
Bio Protoc; 2016 Jun; 6(12):. PubMed ID: 28516113
[TBL] [Abstract][Full Text] [Related]
57. Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.
Löfvall H; Newbould H; Karsdal MA; Dziegiel MH; Richter J; Henriksen K; Thudium CS
Arthritis Res Ther; 2018 Apr; 20(1):67. PubMed ID: 29636095
[TBL] [Abstract][Full Text] [Related]
58. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
59. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
Tani-Ishii N; Tsunoda A; Umemoto T
J Periodontal Res; 1997 Aug; 32(6):480-6. PubMed ID: 9379315
[TBL] [Abstract][Full Text] [Related]
60. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
Kawaguchi H; Chikazu D; Nakamura K; Kumegawa M; Hakeda Y
J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
